IBDEI0NY ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11731,1,5,0)
 ;;=5^Male Erectile Disorder
 ;;^UTILITY(U,$J,358.3,11731,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,11732,0)
 ;;=173.99^^64^703^83
 ;;^UTILITY(U,$J,358.3,11732,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11732,1,4,0)
 ;;=4^173.99
 ;;^UTILITY(U,$J,358.3,11732,1,5,0)
 ;;=5^Skin Cancer NOS
 ;;^UTILITY(U,$J,358.3,11732,2)
 ;;=^340493
 ;;^UTILITY(U,$J,358.3,11733,0)
 ;;=278.01^^64^703^55
 ;;^UTILITY(U,$J,358.3,11733,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11733,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,11733,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,11733,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,11734,0)
 ;;=585.6^^64^703^34
 ;;^UTILITY(U,$J,358.3,11734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11734,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,11734,1,5,0)
 ;;=5^End Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,11734,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,11735,0)
 ;;=482.1^^64^703^81
 ;;^UTILITY(U,$J,358.3,11735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11735,1,4,0)
 ;;=4^482.1
 ;;^UTILITY(U,$J,358.3,11735,1,5,0)
 ;;=5^Pseudomonal Pneumonia
 ;;^UTILITY(U,$J,358.3,11735,2)
 ;;=^269932
 ;;^UTILITY(U,$J,358.3,11736,0)
 ;;=482.2^^64^703^37
 ;;^UTILITY(U,$J,358.3,11736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11736,1,4,0)
 ;;=4^482.2
 ;;^UTILITY(U,$J,358.3,11736,1,5,0)
 ;;=5^H. Influenzae Pneumonia
 ;;^UTILITY(U,$J,358.3,11736,2)
 ;;=^269933
 ;;^UTILITY(U,$J,358.3,11737,0)
 ;;=482.84^^64^703^50
 ;;^UTILITY(U,$J,358.3,11737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11737,1,4,0)
 ;;=4^482.84
 ;;^UTILITY(U,$J,358.3,11737,1,5,0)
 ;;=5^Legionnaires' Disease
 ;;^UTILITY(U,$J,358.3,11737,2)
 ;;=^68817
 ;;^UTILITY(U,$J,358.3,11738,0)
 ;;=482.9^^64^703^17
 ;;^UTILITY(U,$J,358.3,11738,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11738,1,4,0)
 ;;=4^482.9
 ;;^UTILITY(U,$J,358.3,11738,1,5,0)
 ;;=5^Bacterial Pneumonia NOS
 ;;^UTILITY(U,$J,358.3,11738,2)
 ;;=^12347
 ;;^UTILITY(U,$J,358.3,11739,0)
 ;;=430.^^64^703^88
 ;;^UTILITY(U,$J,358.3,11739,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11739,1,4,0)
 ;;=4^430.
 ;;^UTILITY(U,$J,358.3,11739,1,5,0)
 ;;=5^Subarachnoid Hemorrhage
 ;;^UTILITY(U,$J,358.3,11739,2)
 ;;=^114989
 ;;^UTILITY(U,$J,358.3,11740,0)
 ;;=434.91^^64^703^24
 ;;^UTILITY(U,$J,358.3,11740,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11740,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,11740,1,5,0)
 ;;=5^Crb Art Occl,Unspec w/ CRB Inf
 ;;^UTILITY(U,$J,358.3,11740,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,11741,0)
 ;;=431.^^64^703^47
 ;;^UTILITY(U,$J,358.3,11741,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11741,1,4,0)
 ;;=4^431.
 ;;^UTILITY(U,$J,358.3,11741,1,5,0)
 ;;=5^Intracerebral Hemorrhage
 ;;^UTILITY(U,$J,358.3,11741,2)
 ;;=^64977
 ;;^UTILITY(U,$J,358.3,11742,0)
 ;;=432.1^^64^703^89
 ;;^UTILITY(U,$J,358.3,11742,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11742,1,4,0)
 ;;=4^432.1
 ;;^UTILITY(U,$J,358.3,11742,1,5,0)
 ;;=5^Subdural Hemorrhage
 ;;^UTILITY(U,$J,358.3,11742,2)
 ;;=^115061
 ;;^UTILITY(U,$J,358.3,11743,0)
 ;;=784.3^^64^703^8
 ;;^UTILITY(U,$J,358.3,11743,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11743,1,4,0)
 ;;=4^784.3
 ;;^UTILITY(U,$J,358.3,11743,1,5,0)
 ;;=5^Aphasia
 ;;^UTILITY(U,$J,358.3,11743,2)
 ;;=^9453
 ;;^UTILITY(U,$J,358.3,11744,0)
 ;;=784.51^^64^703^30
 ;;^UTILITY(U,$J,358.3,11744,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11744,1,4,0)
 ;;=4^784.51
 ;;^UTILITY(U,$J,358.3,11744,1,5,0)
 ;;=5^Dysarthria
 ;;^UTILITY(U,$J,358.3,11744,2)
 ;;=^338286
 ;;^UTILITY(U,$J,358.3,11745,0)
 ;;=784.59^^64^703^85
 ;;^UTILITY(U,$J,358.3,11745,1,0)
 ;;=^358.31IA^5^2
